Lanthanum Carbonate Chewable Tablets Recalled for Crushed and Broken Tablets
Cipla USA is recalling Lanthanum Carbonate Chewable Tablets (1000mg) distributed nationwide due to complaints of crushed and broken tablets that fail manufacturing specifications.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall involving a prescription medication with physical product defects. No illnesses or injuries have been reported. The recall qualifies as High (Score 3) because it involves a risk-of-harm product where injury has not yet been reported.
Plain-English summary
Cipla USA, Inc. is recalling Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottles (NDC 76282-0478-90), manufactured for Exelan Pharmaceuticals. The product was distributed nationwide. The affected lot is NB240873, which expires March 31, 2026.
The recall was initiated due to failed tablet and capsule specifications. Complaints of crushed and broken tablets were received.
Consumers with affected bottles should contact their pharmacy or healthcare provider for guidance. Patients currently taking this medication should not discontinue use without consulting their healthcare provider.
The recalled product
- Product
- Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Exelan Pharmaceuticals, NDC 76282-0478-90
- Manufacturer
- Cipla USA, Inc.
- Category
- Drug — Chewable Tablets
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot# NB240873
- Exp 03/31/2026
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Cipla USA, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Cipla USA, Inc.
See all →- ModerateCipla Recalls Fosfomycin Tromethamine Due to Impurity Specification Failures
FDA (Drugs) · 2026-10-14
- HighCinacalcet Tablets Recalled for N-Nitroso Impurity Exceeding Limits
FDA (Drugs) · 2026-07-08
- SevereCinacalcet Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2026-07-08
- SevereCinacalcet Hydrochloride Tablets Recalled for Elevated Impurity Levels
FDA (Drugs) · 2026-07-08
- HighCipla cinacalcet 60 mg tablets exceed the nitrosamine daily intake limit
FDA (Drugs) · 2026-04-22
Same hazard · broken tablets
See all →- ModerateLanthanum Carbonate 1000mg Chewable Tablets Recalled for Broken and Crushed Tablets
FDA (Drugs) · 2024-11-20
- ModerateQualitest Recalls Oxycodone and Acetaminophen Tablets Due to Broken Tablets
FDA (Drugs) · 2014-09-10
- ModerateCaraco Recalls Oxcarbazepine Tablets Due to Broken Tablets
FDA (Drugs) · 2014-02-19
- ModerateActavis Recalls Diclofenac Sodium and Misoprostol Tablets Due to Broken Tablets
FDA (Drugs) · 2014-02-12
- ModerateWatson Recalls Hydrocodone and Acetaminophen Tablets Due to Broken Tablets
FDA (Drugs) · 2014-02-05
Similar recalls
- ModerateLanthanum carbonate tablets recalled in a second hardness specification failure
FDA (Drugs) · 2025-12-17
- SevereLanthanum carbonate chewable tablets recalled after failing a hardness specification
FDA (Food) · 2025-12-17
- SevereLanthanum Carbonate Chew Tablets Recalled for Potential Label Mixup
FDA (Drugs) · 2014-01-22
- HighCinacalcet 30 mg tablets recalled over a nitrosamine impurity above limits
FDA (Drugs) · 2025-12-17
- HighLithium Carbonate Extended-Release Tablets Recalled for Temperature Excursion
FDA (Drugs) · 2024-01-03
- HighCinacalcet 90 mg tablets recalled over a nitrosamine impurity above limits
FDA (Drugs) · 2025-12-17